These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11145432)

  • 41. Molecular analysis of the IL-6 receptor in human multiple myeloma, an IL-6-related disease.
    Rodriguez C; Theillet C; Portier M; Bataille R; Klein B
    FEBS Lett; 1994 Mar; 341(2-3):156-61. PubMed ID: 8137932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myeloma biology and therapy. Present status and future developments.
    Nishimoto N; Shima Y; Yoshizaki K; Kishimoto T
    Hematol Oncol Clin North Am; 1997 Feb; 11(1):159-72. PubMed ID: 9081210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines.
    Shiao RT; McLeskey SB; Khera SY; Wolfson A; Freter CE
    Leuk Lymphoma; 1996 Apr; 21(3-4):293-303. PubMed ID: 8726410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
    J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
    Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dimerization and activation of the common transducing chain (gp130) of the cytokines of the IL-6 family by mAb.
    Autissier P; De Vos J; Liautard J; Tupitsyn N; Jacquet C; Chavdia N; Klein B; Brochier J; Gaillard JP
    Int Immunol; 1998 Dec; 10(12):1881-9. PubMed ID: 9885909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute activation of gp130 gene expression in bone marrow stromal cells by contact with myeloma-derived lymphoblastic cell line ARH77 cell membranes.
    Juneja HS; Lee S; Thomazy V; Shipley G; Davies PJ
    J Interferon Cytokine Res; 2001 Mar; 21(3):157-66. PubMed ID: 11331038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
    Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D
    J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two different epitopes of the signal transducer gp130 sequentially cooperate on IL-6-induced receptor activation.
    Pflanz S; Kurth I; Grötzinger J; Heinrich PC; Müller-Newen G
    J Immunol; 2000 Dec; 165(12):7042-9. PubMed ID: 11120832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. C-kit ligand (SCF) in human multiple myeloma cells.
    Lemoli RM; Fortuna A
    Leuk Lymphoma; 1996 Feb; 20(5-6):457-64. PubMed ID: 8833403
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines.
    Gaillard JP; Liautard J; Klein B; Brochier J
    Eur J Immunol; 1997 Dec; 27(12):3332-40. PubMed ID: 9464821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of the bcl-2 family of pro- and anti-apoptotic genes in multiple myeloma and normal plasma cells: regulation during interleukin-6(IL-6)-induced growth and survival.
    Spets H; Strömberg T; Georgii-Hemming P; Siljason J; Nilsson K; Jernberg-Wiklund H
    Eur J Haematol; 2002 Aug; 69(2):76-89. PubMed ID: 12366710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
    Malaval L; Liu F; Vernallis AB; Aubin JE
    J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
    Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma.
    Karczewska A; Nawrocki S; Breborowicz D; Filas V; Mackiewicz A
    Cancer; 2000 May; 88(9):2061-71. PubMed ID: 10813718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of interleukin 6 in the growth of myeloma-derived cell lines.
    Barut BA; Zon LI; Cochran MK; Paul SR; Chauhan D; Mohrbacher A; Fingeroth J; Anderson KC
    Leuk Res; 1992 Oct; 16(10):951-9. PubMed ID: 1405708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases.
    Hausherr A; Tavares R; Schäffer M; Obermeier A; Miksch C; Mitina O; Ellwart J; Hallek M; Krause G
    Oncogene; 2007 Jul; 26(34):4987-98. PubMed ID: 17310994
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activating mutations in the N- and K-ras oncogenes differentially affect the growth properties of the IL-6-dependent myeloma cell line ANBL6.
    Billadeau D; Liu P; Jelinek D; Shah N; LeBien TW; Van Ness B
    Cancer Res; 1997 Jun; 57(11):2268-75. PubMed ID: 9187131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130.
    Taga T; Narazaki M; Yasukawa K; Saito T; Miki D; Hamaguchi M; Davis S; Shoyab M; Yancopoulos GD; Kishimoto T
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10998-1001. PubMed ID: 1438305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.